{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:57:47Z","timestamp":1785826667383,"version":"3.56.0"},"reference-count":61,"publisher":"Pharmaceutical Society of Japan","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biological & Pharmaceutical Bulletin","Biol. Pharm. Bull."],"published-print":{"date-parts":[[2024,5,24]]},"DOI":"10.1248\/bpb.b23-00737","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T22:13:01Z","timestamp":1716502381000},"page":"1008-1020","source":"Crossref","is-referenced-by-count":14,"title":["Linagliptin Mitigates TGF-\u03b21 Mediated Epithelial\u2013Mesenchymal Transition in Tacrolimus-Induced Renal Interstitial Fibrosis <i>via<\/i> Smad\/ERK\/P38 and HIF-1\u03b1\/LOXL2 Signaling Pathways"],"prefix":"10.1248","volume":"47","author":[{"given":"Mohamed E.","family":"Nady","sequence":"first","affiliation":[{"name":"Department of Pharmacology & Toxicology, Faculty of Pharmacy, Al-Azhar University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola M.","family":"Abd El-Raouf","sequence":"additional","affiliation":[{"name":"Pharmacology Department, Egyptian Drug Authority (EDA), formerly known as National Organization for Drug Control and Research (NODCAR)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El-Sayed M.","family":"El-Sayed","sequence":"additional","affiliation":[{"name":"Department of Pharmacology & Toxicology, Faculty of Pharmacy, Al-Azhar University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"163","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Gwon MG, An HJ, Gu H, Kim YA, Han SM, Park KK. Apamin inhibits renal fibrosis via<\/i> suppressing TGF-\u03b21 and STAT3 signaling in vivo<\/i> and in vitro.<\/i> J. Mol. Med.<\/i>, 99<\/b>, 1265\u20131277 (2021).","DOI":"10.1007\/s00109-021-02087-x"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Gonzales HM, McGillicuddy JW, Rohan V, Chandler JL, Nadig SN, Dubay DA, Taber DJ. A comprehensive review of the impact of tacrolimus intrapatient variability on clinical outcomes in kidney transplantation. Am. J. Transplant.<\/i>, 20<\/b>, 1969\u20131983 (2020).","DOI":"10.1111\/ajt.16002"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Farouk SS, Rein JL. The many faces of calcineurin inhibitor toxicity-what the FK? Adv. Chronic Kidney Dis.<\/i>, 27<\/b>, 56\u201366 (2020).","DOI":"10.1053\/j.ackd.2019.08.006"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Ho\u0161kov\u00e1 L, M\u00e1lek I, Kopkan L, Kautzner J. Pathophysiological mechanisms of calcineurin inhibitor-induced nephrotoxicity and arterial hypertension. Physiol. Res.<\/i>, 66<\/b>, 167\u2013180 (2017).","DOI":"10.33549\/physiolres.933332"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Nagavally RR, Sunilkumar S, Akhtar M, Trombetta LD, Ford SM. Chrysin ameliorates cyclosporine-A-induced renal fibrosis by inhibiting TGF-\u03b21-induced epithelial-mesenchymal transition. Int. J. Mol. Sci.<\/i>, 22<\/b>, 10252 (2021).","DOI":"10.3390\/ijms221910252"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Zhang Y, Yin N, Sun A, Wu Q, Hu W, Hou X, Zeng X, Zhu M, Liao Y. Transient receptor potential channel 6 knockout ameliorates kidney fibrosis by inhibition of epithelial\u2013mesenchymal transition. Front. Cell Dev. Biol.<\/i>, 8<\/b>, 602703 (2021).","DOI":"10.3389\/fcell.2020.602703"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Di Gregorio J, Robuffo I, Spalletta S, Giambuzzi G, De Iuliis V, Toniato E, Martinotti S, Conti P, Flati V. The epithelial-to-mesenchymal transition as a possible therapeutic target in fibrotic disorders. Front. Cell Dev. Biol.<\/i>, 8<\/b>, 607483 (2020).","DOI":"10.3389\/fcell.2020.607483"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Lee JA, Shin MR, Roh SS. Corni fructus alleviates UUO-induced renal fibrosis via<\/i> TGF-\u03b2\/Smad signaling. Biomed. Res. Int.<\/i>, 2022<\/b>, 5780964 (2022).","DOI":"10.1155\/2022\/5780964"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Gu L, Wang Y, Yang G, Tilyek A, Zhang C, Li S, Yu B, Chai C, Cao Z. Ribes diacanthum Pall (RDP) ameliorates UUO-induced renal fibrosis via<\/i> both canonical and non-canonical TGF-\u03b2 signaling pathways in mice. J. Ethnopharmacol.<\/i>, 231<\/b>, 302\u2013310 (2019).","DOI":"10.1016\/j.jep.2018.10.023"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Nazari Soltan Ahmad S, Kalantary-Charvadeh A, Hamzavi M, Ezzatifar F, Aboutalebi Vand Beilankouhi E, Toofani-Milani A, Geravand F, Golshadi Z, Mesgari-Abbasi M. TGF-\u03b21 receptor blockade attenuates unilateral ureteral obstruction-induced renal fibrosis in C57BL\/6 mice through attenuating Smad and MAPK pathways. J. Mol. Histol.<\/i>, 53<\/b>, 691\u2013698 (2022).","DOI":"10.1007\/s10735-022-10078-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Khalil R, Shata A, Abd El-Kader EM, Sharaf H, Abdo WS, Amin NA, Saber S. Vildagliptin, a DPP-4 inhibitor, attenuates carbon tetrachloride-induced liver fibrosis by targeting ERK1\/2, p38\u03b1, and NF-\u03baB signaling. Toxicol. Appl. Pharmacol.<\/i>, 407<\/b>, 115246 (2020).","DOI":"10.1016\/j.taap.2020.115246"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Hough C, Radu M, Dor\u00e9 JJ. TGF-beta induced Erk phosphorylation of Smad linker region regulates Smad signaling. PLOS ONE<\/i>, 7<\/b>, e42513 (2012).","DOI":"10.1371\/journal.pone.0042513"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Zhou J, Jiang H, Jiang H, Fan Y, Zhang J, Ma X, Yang X, Sun Y, Zhao X. The ILEI\/LIFR complex induces EMT via<\/i> the Akt and ERK pathways in renal interstitial fibrosis. J. Transl. Med.<\/i>, 20<\/b>, 54 (2022).","DOI":"10.1186\/s12967-022-03265-2"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Meng XM, Nikolic-Paterson DJ, Lan HY. TGF-\u03b2: the master regulator of fibrosis. Nat. Rev. Nephrol.<\/i>, 12<\/b>, 325\u2013338 (2016).","DOI":"10.1038\/nrneph.2016.48"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Ndibalema AR, Kabuye D, Wen S, Li L, Li X, Fan Q. Empagliflozin protects against proximal renal tubular cell injury induced by high glucose via<\/i> regulation of hypoxia-inducible factor 1-alpha. Diabetes Metab. Syndr. Obes.<\/i>, 13<\/b>, 1953\u20131967 (2020).","DOI":"10.2147\/DMSO.S243170"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Ning X, Zhang K, Wu Q, Liu M, Sun S. Emerging role of Twist1 in fibrotic diseases. J. Cell. Mol. Med.<\/i>, 22<\/b>, 1383\u20131391 (2018).","DOI":"10.1111\/jcmm.13465"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Wei X, Zhu X, Jiang L, Huang X, Zhang Y, Zhao D, Du Y. Recent advances in understanding the role of hypoxia-inducible factor 1\u03b1 in renal fibrosis. Int. Urol. Nephrol.<\/i>, 52<\/b>, 1287\u20131295 (2020).","DOI":"10.1007\/s11255-020-02474-2"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Lu J, Qian Y, Jin W, Tian R, Zhu Y, Wang J, Meng X, Wang R. Hypoxia-inducible factor-1\u03b1 regulates epithelial-to-mesenchymal transition in paraquat-induced pulmonary fibrosis by activating lysyl oxidase. Exp. Ther. Med.<\/i>, 15<\/b>, 2287\u20132294 (2018). https:\/\/www.spandidos-publications.com\/10.3892\/etm.2017.5677\/abstract","DOI":"10.3892\/etm.2017.5677"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Fan Z, Zheng W, Li H, Wu W, Liu X, Sun Z, Hu H, Du L, Jia Q, Liu Q. LOXL2 upregulates hypoxia-inducible factor-1\u03b1 signaling through Snail-FBP1 axis in hepatocellular carcinoma cells. Oncol. Rep.<\/i>, 43<\/b>, 1641\u20131649 (2020).","DOI":"10.3892\/or.2020.7541"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Rosenstock J, Perkovic V, Alexander JH, Cooper ME, Marx N, Pencina MJ, Toto RD, Wanner C, Zinman B, Baanstra D, Pfarr E, Mattheus M, Broedl UC, Woerle HJ, George JT, von Eynatten M, McGuire DK. Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA\u00ae<\/sup>): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk. Cardiovasc. Diabetol.<\/i>, 17<\/b>, 39 (2018).","DOI":"10.1186\/s12933-018-0682-3"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Mayer AL, Scheitacker I, Ebert N, Klein T, Amann K, Daniel C. The dipeptidyl peptidase 4 inhibitor linagliptin ameliorates renal injury and accelerated resolution in a rat model of crescentic nephritis. Br. J. Pharmacol.<\/i>, 178<\/b>, 878\u2013895 (2021).","DOI":"10.1111\/bph.15320"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Kanasaki K. The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin. Clin. Sci. <\/i>(Lond.), 132<\/b>, 489\u2013507 (2018).","DOI":"10.1042\/CS20180031"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Penno G, Garofolo M, Del Prato S. Dipeptidyl peptidase-4 inhibition in chronic kidney disease and potential for protection against diabetes-related renal injury. Nutr. Metab. Cardiovasc. Dis.<\/i>, 26<\/b>, 361\u2013373 (2016).","DOI":"10.1016\/j.numecd.2016.01.001"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Castoldi G, Carletti R, Ippolito S, Colzani M, Barzaghi F, Stella A, Zerbini G, Perseghin G, Zatti G, di Gioia CRT. Sodium-glucose cotransporter 2 inhibition prevents renal fibrosis in cyclosporine nephropathy. Acta Diabetol.<\/i>, 58<\/b>, 1059\u20131070 (2021).","DOI":"10.1007\/s00592-021-01681-2"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Clark JD, Gebhart GF, Gonder JC, Keeling ME, Kohn DF. Special report: the 1996 guide for the care and use of laboratory animals. ILAR J.<\/i>, 38<\/b>, 41\u201348 (1997).","DOI":"10.1093\/ilar.38.1.41"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Ko EJ, Shin YJ, Cui S, Lim SW, Chung BH, Yang CW. Effect of dual inhibition of DPP4 and SGLT2 on tacrolimus-induced diabetes mellitus and nephrotoxicity in a rat model. Am. J. Transplant.<\/i>, 22<\/b>, 1537\u20131549 (2022).","DOI":"10.1111\/ajt.17035"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) El-Ghannam MS, Saad MA, Nassar NN, El-Yamany MF, El-Bahy AAZ. Linagliptin ameliorates acetic acid-induced colitis via<\/i> modulating AMPK\/SIRT1\/PGC-1\u03b1 and JAK2\/STAT3 signaling pathway in rats. Toxicol. Appl. Pharmacol.<\/i>, 438<\/b>, 115906 (2022).","DOI":"10.1016\/j.taap.2022.115906"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Siddiqui N, Ali J, Parvez S, Zameer S, Najmi AK, Akhtar M. Linagliptin, a DPP-4 inhibitor, ameliorates A\u03b2 (1-42) peptides induced neurodegeneration and brain insulin resistance (BIR) via<\/i> insulin receptor substrate-1 (IRS-1) in rat model of Alzheimer\u2019s disease. Neuropharmacology<\/i>, 195<\/b>, 108662 (2021).","DOI":"10.1016\/j.neuropharm.2021.108662"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Sharma A, Fish BL, Moulder JE, Medhora M, Baker JE, Mader M, Cohen EP. Safety and blood sample volume and quality of a refined retro-orbital bleeding technique in rats using a lateral approach. Lab Anim.<\/i> (NY), 43<\/b>, 63\u201366 (2014).","DOI":"10.1038\/laban.432"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Landini G, Martinelli G, Piccinini F. Colour deconvolution: stain unmixing in histological imaging. Bioinformatics<\/i>, 37<\/b>, 1485\u20131487 (2021).","DOI":"10.1093\/bioinformatics\/btaa847"},{"key":"31","unstructured":"31) Suvarna KS, Layton C, Bancroft JD. Bancroft\u2019s theory and practice of histological techniques.<\/i> 7th ed., Churchill Livingstone, New York (2012)."},{"key":"32","unstructured":"32) Drury RAB, Wallington EA. Carleton\u2019s histological technique<\/i>. 5th ed., Oxford University Press, Oxford (1980)."},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem.<\/i>, 72<\/b>, 248\u2013254 (1976).","DOI":"10.1006\/abio.1976.9999"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Zhu JH, Wang L, Ma ZX, Duan JA, Tao JH. Rehmannia glutinosa Libosch and Cornus officinalis Sieb herb couple ameliorates renal interstitial fibrosis in CKD rats by inhibiting the TGF-\u03b21\/MAPK signaling pathway. J. Ethnopharmacol.<\/i>, 318<\/b> (Pt. B), 117039 (2024).","DOI":"10.1016\/j.jep.2023.117039"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Ohm B, Moneke I, Jungraithmayr W. Targeting cluster of differentiation 26\/dipeptidyl peptidase 4 (CD26\/DPP4) in organ fibrosis. Br. J. Pharmacol.<\/i>, 180<\/b>, 2846\u20132861 (2023).","DOI":"10.1111\/bph.15967"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Shi S, Srivastava SP, Kanasaki M, He J, Kitada M, Nagai T, Nitta K, Takagi S, Kanasaki K, Koya D. Interactions of DPP-4 and integrin beta1 influences endothelial-to-mesenchymal transition. Kidney Int.<\/i>, 88<\/b>, 479\u2013489 (2015).","DOI":"10.1038\/ki.2015.103"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Soare A, Gy\u00f6rfi HA, Matei AE, Dees C, Rauber S, Wohlfahrt T, Chen CW, Ludolph I, Horch RE, B\u00e4uerle T, von H\u00f6rsten S, Mihai C, Distler O, Ramming A, Schett G, Distler JHW. Dipeptidylpeptidase 4 as a marker of activated fibroblasts and a potential target for the treatment of fibrosis in systemic sclerosis. Arthritis Rheumatol.<\/i>, 72<\/b>, 137\u2013149 (2020).","DOI":"10.1002\/art.41058"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Lee SY, Wu ST, Liang YJ, Su MJ, Huang CW, Jao YH, Ku HC. Soluble dipeptidyl peptidase-4 induces fibroblast activation through proteinase-activated receptor-2. Front. Pharmacol.<\/i>, 11<\/b>, 552818 (2020).","DOI":"10.3389\/fphar.2020.552818"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Wen Y, Parikh CR. Current concepts and advances in biomarkers of acute kidney injury. Crit. Rev. Clin. Lab. Sci.<\/i>, 58<\/b>, 354\u2013368 (2021).","DOI":"10.1080\/10408363.2021.1879000"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Fu R, Tajima S, Shigematsu T, Zhang M, Tsuchimoto A, Egashira N, Ieiri I, Masuda S. Establishment of an experimental rat model of tacrolimus-induced kidney injury accompanied by interstitial fibrosis. Toxicol. Lett.<\/i>, 341<\/b>, 43\u201350 (2021).","DOI":"10.1016\/j.toxlet.2021.01.020"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Shigematsu T, Tajima S, Fu R, Zhang M, Itoyama Y, Tsuchimoto A, Egashira N, Ieiri I. The mTOR inhibitor everolimus attenuates tacrolimus-induced renal interstitial fibrosis in rats. Life Sci.<\/i>, 288<\/b>, 120150 (2022).","DOI":"10.1016\/j.lfs.2021.120150"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Figueroa SM, Bertocchio JP, Nakamura T, El-Moghrabi S, Jaisser F, Amador CA. The mineralocorticoid receptor on smooth muscle cells promotes tacrolimus-induced renal injury in mice. Pharmaceutics<\/i>, 15<\/b>, 1373 (2023).","DOI":"10.3390\/pharmaceutics15051373"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Oraby MA, El-Yamany MF, Safar MM, Assaf N, Ghoneim HA. Amelioration of early markers of diabetic nephropathy by linagliptin in fructose-streptozotocin-induced type 2 diabetic rats. Nephron<\/i>, 141<\/b>, 273\u2013286 (2019).","DOI":"10.1159\/000495517"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Sharma A, Jain S, Gupta R, Guleria S, Agarwal S, Dinda A. Calcineurin inhibitor toxicity in renal allografts: morphologic clues from protocol biopsies. Indian J. Pathol. Microbiol.<\/i>, 53<\/b>, 651\u2013657 (2010). https:\/\/journals.lww.com\/ijpm\/fulltext\/2010\/53040\/calcineurin_inhibitor_toxicity_in_renal.10.aspx","DOI":"10.4103\/0377-4929.72015"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Aboulmagd YM, El-Bahy AAZ, Menze ET, Azab SS, El-Demerdash E. Role of linagliptin in preventing the pathological progression of hepatic fibrosis in high fat diet and streptozotocin-induced diabetic obese rats. Eur. J. Pharmacol.<\/i>, 881<\/b>, 173224 (2020).","DOI":"10.1016\/j.ejphar.2020.173224"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Wang D, Chen X, Fu M, Xu H, Li Z. Tacrolimus increases the expression level of the chemokine receptor CXCR2 to promote renal fibrosis progression. Int. J. Mol. Med.<\/i>, 44<\/b>, 2181\u20132188 (2019).","DOI":"10.3892\/ijmm.2019.4368"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Luo K, Lim SW, Jin J, Jin L, Gil HW, Im DS, Hwang HS, Yang CW. Cilastatin protects against tacrolimus-induced nephrotoxicity via<\/i> anti-oxidative and anti-apoptotic properties. BMC Nephrol.<\/i>, 20<\/b>, 221 (2019).","DOI":"10.1186\/s12882-019-1399-6"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Bloch J, Hazzan M, Van der Hauwaert C, Buob D, Savary G, Hertig A, Gnemmi V, Frimat M, Perrais M, Copin MC, Broly F, No\u00ebl C, Pottier N, Cauffiez C, Glowacki F. Donor ABCB1 genetic polymorphisms influence epithelial-to-mesenchyme transition in tacrolimus-treated kidney recipients. Pharmacogenomics<\/i>, 15<\/b>, 2011\u20132024 (2014).","DOI":"10.2217\/pgs.14.146"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Zhang S, Huang Q, Cai X, Jiang S, Xu N, Zhou Q, Cao X, Hultstr\u00f6m M, Tian J, Lai EY. Osthole ameliorates renal fibrosis in mice by suppressing fibroblast activation and epithelial-mesenchymal transition. Front. Physiol.<\/i>, 9<\/b>, 1650 (2018).","DOI":"10.3389\/fphys.2018.01650"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Huang CW, Lee SY, Du CX, Ku HC. Soluble dipeptidyl peptidase-4 induces epithelial-mesenchymal transition through tumor growth factor-\u03b2 receptor. Pharmacol. Rep.<\/i>, 75<\/b>, 1005\u20131016 (2023).","DOI":"10.1007\/s43440-023-00496-y"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51) Zhou D, Liu Y. Renal fibrosis in 2015: understanding the mechanisms of kidney fibrosis. Nat. Rev. Nephrol.<\/i>, 12<\/b>, 68\u201370 (2016).","DOI":"10.1038\/nrneph.2015.215"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52) Schinner E, Wetzl V, Schramm A, Kees F, Sandner P, Stasch JP, Hofmann F, Schlossmann J. Inhibition of the TGF\u03b2 signalling pathway by cGMP and cGMP-dependent kinase I in renal fibrosis. FEBS Open Bio<\/i>, 7<\/b>, 550\u2013561 (2017).","DOI":"10.1002\/2211-5463.12202"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53) Lim JH, Oh EJ, Oh SH, Jung HY, Choi JY, Cho JH, Park SH, Kim YL, Kim CD. Renoprotective effects of alpha-1 antitrypsin against tacrolimus-induced renal injury. Int. J. Mol. Sci.<\/i>, 21<\/b>, 8628 (2020).","DOI":"10.3390\/ijms21228628"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54) Bai F, Zhang LH, Zhang WW, Zheng RH, Eskew JR, Bennett J, Wang NP, Bose HS, Zhao ZQ. Conservation of glucagon like peptide-1 level with liraglutide and linagilptin protects the kidney against angiotensin II-induced tissue fibrosis in rats. Eur. J. Pharmacol.<\/i>, 867<\/b>, 172844 (2020).","DOI":"10.1016\/j.ejphar.2019.172844"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55) Zhu FQ, Chen MJ, Zhu M, Zhao RS, Qiu W, Xu X, Liu H, Zhao HW, Yu RJ, Wu XF, Zhang K, Huang H. Curcumin suppresses epithelial-mesenchymal transition of renal tubular epithelial cells through the inhibition of Akt\/mTOR pathway. Biol. Pharm. Bull.<\/i>, 40<\/b>, 17\u201324 (2017).","DOI":"10.1248\/bpb.b16-00364"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56) Luo F, Xu R, Song G, Xue D, He X, Xia Y. Alleviation of TGF-\u03b21 induced tubular epithelial\u2013mesenchymal transition via<\/i> the \u03b4-opioid receptor. FEBS J.<\/i>, 288<\/b>, 1243\u20131258 (2021).","DOI":"10.1111\/febs.15459"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57) Hasan AA, von Websky K, Reichetzeder C, Tsuprykov O, Gaballa MMS, Guo J, Zeng S, Deli\u0107 D, Tammen H, Klein T, Kleuser B, Hocher B. Mechanisms of GLP-1 receptor-independent renoprotective effects of the dipeptidyl peptidase type 4 inhibitor linagliptin in GLP-1 receptor knockout mice with 5\/6 nephrectomy. Kidney Int.<\/i>, 95<\/b>, 1373\u20131388 (2019).","DOI":"10.1016\/j.kint.2019.01.010"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58) Zhang YE. Mechanistic insight into contextual TGF-\u03b2 signaling. Curr. Opin. Cell Biol.<\/i>, 51<\/b>, 1\u20137 (2018).","DOI":"10.1016\/j.ceb.2017.10.001"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59) Azouz AA, Omar HA, Hersi F, Ali FEM, Hussein Elkelawy AMM. Impact of the ACE2 activator xanthenone on tacrolimus nephrotoxicity: Modulation of uric acid\/ERK\/p38 MAPK and Nrf2\/SOD3\/GCLC signaling pathways. Life Sci.<\/i>, 288<\/b>, 120154 (2022).","DOI":"10.1016\/j.lfs.2021.120154"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60) Pr\u00f3kai \u00c1, Csoh\u00e1ny R, Sziksz E, Pap D, Balicza-Himer L, Boros S, Magda B, Vannay \u00c1, Kis-Petik K, Fekete A, Peti-Peterdi J, Szab\u00f3 AJ. Calcineurin-inhibition results in upregulation of local renin and subsequent vascular endothelial growth factor production in renal collecting ducts. Transplantation<\/i>, 100<\/b>, 325\u2013333 (2016).","DOI":"10.1097\/TP.0000000000000961"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61) Kabei K, Tateishi Y, Nozaki M, Tanaka M, Shiota M, Osada-Oka M, Nishide S, Uchida J, Nakatani T, Tomita S, Miura K. Role of hypoxia-inducible factor-1 in the development of renal fibrosis in mouse obstructed kidney: special references to HIF-1 dependent gene expression of profibrogenic molecules. J. Pharmacol. Sci.<\/i>, 136<\/b>, 31\u201338 (2018).","DOI":"10.1016\/j.jphs.2017.12.004"}],"container-title":["Biological and Pharmaceutical Bulletin"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/5\/47_b23-00737\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T03:27:41Z","timestamp":1716607661000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/bpb\/47\/5\/47_b23-00737\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,24]]},"references-count":61,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1248\/bpb.b23-00737","relation":{},"ISSN":["0918-6158","1347-5215"],"issn-type":[{"value":"0918-6158","type":"print"},{"value":"1347-5215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,24]]},"article-number":"b23-00737"}}